VCM
LLY icon

Versant Capital Management’s Eli Lilly LLY Stock Holding History

Versant Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Buy
3,562
+16
+0.5% +$16.3K 0.38% 43
2026
Q1 		$3.26M Buy
3,546
+758
+27% +$768K 0.32% 45
2025
Q4 		$3M Buy
2,788
+528
+23% +$505K 0.38% 39
2025
Q3 		$1.72M Buy
2,260
+743
+49% +$553K 0.23% 64
2025
Q2 		$1.18M Sell
1,517
-444
-23% -$345K 0.18% 66
2025
Q1 		$1.62M Buy
1,961
+794
+68% +$661K 0.27% 51
2024
Q4 		$901K Buy
1,167
+188
+19% +$156K 0.19% 65
2024
Q3 		$867K Buy
979
+84
+9% +$75.5K 0.2% 62
2024
Q2 		$810K Buy
895
+159
+22% +$127K 0.21% 60
2024
Q1 		$573K Buy
736
+13
+2% +$9.25K 0.16% 67
2023
Q4 		$421K Sell
723
-15
-2% -$8.76K 0.13% 80
2023
Q3 		$396K Sell
738
-5
-0.7% -$2.58K 0.13% 81
2023
Q2 		$348K Sell
743
-5
-0.7% -$2.1K 0.11% 84
2023
Q1 		$257K Buy
748
+296
+65% +$99.8K 0.09% 105
2022
Q4 		$165K Sell
452
-17
-4% -$6.03K 0.06% 112
2022
Q3 		$152K Sell
469
-2
-0.4% -$634 0.06% 116
2022
Q2 		$153K Hold
471
– – 0.06% 115
2022
Q1 		$135K Hold
471
– – 0.04% 143
2021
Q4 		$130K Hold
471
– – 0.04% 133
2021
Q3 		$109K Sell
471
-23
-5% -$5.68K 0.04% 140
2021
Q2 		$113K Sell
494
-62,575
-99% -$12.6M 0.04% 134
2021
Q1 		$11.8M Sell
63,069
-97
-0.2% -$19K 4.29% 6
2020
Q4 		$10.7M Sell
63,166
-1,500
-2% -$224K 4.2% 6
2020
Q3 		$9.57M Hold
64,666
– – 4.27% 6
2020
Q2 		$10.6M Sell
64,666
-10
-0% -$1.53K 4.87% 5
2020
Q1 		$8.97M Sell
64,676
-100
-0.2% -$13.7K 4.72% 5
2019
Q4 		$8.51M Sell
64,776
-37
-0.1% -$4.29K 4.29% 5
2019
Q3 		$7.25M Buy
64,813
+4,112
+7% +$458K 3.4% 7
2019
Q2 		$6.72M Sell
60,701
-261
-0.4% -$30.7K 3.07% 8
2019
Q1 		$7.91M Hold
60,962
– – 3.37% 7
2018
Q4 		$7.05M Buy
60,962
+4,600
+8% +$514K 3.25% 8
2018
Q3 		$6.05M Sell
56,362
-1,693
-3% -$169K 2.47% 9
2018
Q2 		$4.95M Sell
58,055
-110
-0.2% -$9.04K 2.09% 14
2018
Q1 		$4.5M Sell
58,165
-49
-0.1% -$3.94K 1.86% 15
2017
Q4 		$4.92M Buy
58,214
+57,400
+7,052% +$4.88M 1.99% 15
2017
Q3 		$69K Sell
814
-17
-2% -$1.39K 0.04% 190
2017
Q2 		$68K Sell
831
-5
-0.6% -$408 0.04% 189
2017
Q1 		$70K Hold
836
– – 0.04% 190
2016
Q4 		$61K Sell
836
-119
-12% -$8.86K 0.03% 220
2016
Q3 		$76K Sell
955
-2
-0.2% -$160 0.04% 168
2016
Q2 		$75K Sell
957
-45
-4% -$3.39K 0.04% 165
2016
Q1 		$72K Sell
1,002
-33
-3% -$2.5K 0.04% 164
2015
Q4 		$87K Buy
+1,035
New +$85.9K 0.05% 141

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Versant Capital Management's LLY Position: Q2 2026 in Review

Versant Capital Management increased its Eli Lilly (LLY) stake by 0.45% in Q2 2026, buying an estimated $16.3K and bringing the position to 3,562 shares worth $4.27M. The position accounts for 0.38% of the portfolio, ranked #43.

Versant Capital Management first reported a position in LLY in Q4 2015 and has held it in 43 quarters since. The position peaked at $11.8M in Q1 2021. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Versant Capital Management held 3,562 shares of Eli Lilly worth $4.27M as of Q2 2026.
  • Versant Capital Management bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.38% of Versant Capital Management's portfolio in Q2 2026, its #43 holding.
  • Versant Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Eli Lilly position peaked at $11.8M in Q1 2021.
  • 1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.